ArticleJournal of cellular and molecular medicine2017

Carbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction.

Xiling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.